Treatment of H-Ras-driven tumors

• 收藏
• 分享

专利权人:

Memorial Sloan-Kettering Cancer Center

发明人:

Fagin, James A.,Knauf, Jeffrey A.,Untch, Brian R.

申请号：

AU2015249225

公开号：

AU2015249225B2

申请日:

2015.04.27

申请国别(地区):

AU

年份:

2019

代理人:

摘要：

The present disclosure describes a compositions and methods for treatment of Hras-driven cancers. Administration of a farnesyltransferase inhibitor, for example, tipifarnib, alone or in combination with a MEK inhibitor can reduce tumor size and tumor growth in cancers such as poorly differentiated thyroid cancer (PDTC) and anaplastic thyroid cancer (ATC)

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/